PlatformQ Health

PQH News

OMedLive, an online oncology learning channel from PlatformQ Health Education, will be in Chicago for the ASCO Annual Meeting from June 1-5. Our commitment to oncology practice and cancer care makes this one of the most exciting events for our team, because it gives us an opportunity to explain how we’re improving healthcare outcomes through…

Read More >>


PlatformQ Health was proud to present two posters – a traditional poster and an e-poster – at this year’s Annual Meeting of the American Academy of Neurology. Alongside VP of Education Jayne Chaplick, Senior Medical Director Anne Roc attended to present the posters, which focus on insights from previous PQH educational initiatives. While at the meeting,…

Read More >>


The Spring session of CMEpalooza featured two full days of live programming designed for the continuing medical education community. This year, PlatformQ Health (PQH) sent two delegates to the session titled Including Patients and Patient Advocacy Groups in Educational Planning & Delivery: How to Make It a “Win-Win”. Senior VP of Education, Kathryn Pucci, acted…

Read More >>


PlatformQ Health will present a poster at the Alliance Industry Summit (AIS) 2018 “Best in Class Outcomes Awards” Monday, May 7, 2018 highlighting a series of diabetes programs for clinicians created in collaboration with the renowned Joslin Diabetes Center. The poster, Better Targeting of Serial Education through Formative Qualitative Evaluation, will focus on how advanced…

Read More >>


PlatformQ Health is pleased to announce our education team will present two poster sessions at the 2018 Annual Meeting of the American Academy of Neurology April 23 and 24 in Los Angeles, California. “We’re proud to be selected to share insights from two of our educational initiatives, one in Multiple Sclerosis (MS) and another in…

Read More >>


March 25 through March 31 marks National Physicians’ Week, a time dedicated to recognizing and thanking doctors for the sacrifices they make to take care of all of us. Doctors work tirelessly to help people when they are most in need, and in spite of the important role they play in our lives, they often…

Read More >>


Log into PainCareLive on Tuesday, March 13, 2018 at 2:00 PM ET for a live online CME Certified activity discussing the safety, efficacy, and tolerability profiles of abuse-deterrent opioid formulations and their potential to reduce opioid misuse/abuse in treating patients with acute or chronic pain.  This accredited program, Targeting Opioid Misuse: Abuse-Deterrent Formulations in the Management…

Read More >>


World Rare Disease Day is celebrated on the last day of February each year (often February 28, “rarely” on leap day). Since 2008, this day has grown into a global initiative involving more than 90 countries and hundreds of cities to raise awareness of rare diseases and encourage researchers and leaders to address the needs…

Read More >>


The biggest yearly gathering in CME, the Alliance Annual Conference, just wrapped up in Orlando, Florida, after several engaging days of programming around the theme Destination: Patient Outcomes. Our Journey to Improving Patient Care. Several members of the PlatformQ Health Education (PQH Education) leadership team were in attendance, and we were happy to be able…

Read More >>


On February 9, 2018 at 10:00 am EST, join CardioCareLive for a roundtable discussion on the new guidelines for the treatment of heart failure. In this second part of our series on Implementing Guideline-Directed Medical Therapy for Patients with Heart Failure, the panelists will discuss multidisciplinary approaches to implementing the guidelines – specifically, the challenges…

Read More >>


February is shaping up to be a busy time on the PlatformQ Health network. This month’s live broadcasts include a panel discussion on the new Heart Failure Guidelines and information about the latest treatment strategies for schizophrenia, as well as programs with Association of Community Cancer Centers (ACCC) and Depression and Bipolar Support Alliance (DBSA)…

Read More >>


PlatformQ Health Education (PQH Education) was proud to send several delegates to the 2018 Alliance Annual Conference January 21 and 22 in Orlando, Florida. The Alliance Annual Conference is the largest gathering in CME, and this year’s theme was Destination: Patient Outcomes. Our Journey to Improving Patient Care. In addition to presenting two sessions and…

Read More >>


PlatformQ Health Education, in joint providership with the American Academy of Family Physicians (AAFP), announces the first of two online educational programs on shared decision making in major depressive disorder (MDD) treatment. Major depressive disorder (MDD) has substantial negative effects on patients’ functional abilities and quality of life. This tethered, or mutual, education will focus…

Read More >>


Please join us in congratulating Wendy Turell as she receives an Alliance Leadership Award in recognition of her service and direction as Chair of the Alliance Research Committee. The Opening Night Awards Dinner will take place January 20th from 5:30 – 7:30pm, kicking off the annual conference with a celebration of the education industry and…

Read More >>


The inaugural program for CancerCoachLive, PlatformQ Health’s educational channel for patients with cancer, was launched in 2016 through a partnership with The Leukemia & Lymphoma Society (LLS) focusing on educating patients with B-cell non-Hodgkin lymphomas (NHL).  Building on LLS’s goal to empower patients through education, this program aimed to improve knowledge and self-efficacy on B-cell NHL…

Read More >>


  PlatformQ Health Education (PQH Education) is pleased to announce we will be presenting two sessions at the upcoming 2018 Alliance Annual Conference January 21 and 22 in Orlando, Florida.  The Alliance Annual Conference is the largest gathering in CME, bringing together professionals in continuing healthcare education from across the spectrum of organization settings.  These…

Read More >>


Healthcare professionals and policymakers are struggling to come to terms with the epidemic of opioid abuse and overdose in the United States – perhaps nowhere more than here in Massachusetts, where the presence of premier medical institutions has not been able to stem the state’s record high rates of opioid-overdose deaths (which are among the…

Read More >>


Our understanding of congestion heart failure has been rapidly evolving over the past decade.  Heart failure is a leading cause of mortality globally and in the US. It is the final end-point of various cardiac diseases.  When the cardiac muscles fail, hypertrophy of the cardiac muscle cells is commonly observed. This hypertrophy of cardiomyoctes is…

Read More >>



We’re proud to have 4 abstracts accepted for publication for the 2017 ASCO Annual Meeting. Educating oncologists and empowering cancer patients in the 21st century means delivering precision education that supports precision medicine. We hope you’ll take some time to learn more about how our precision education platform supports precision medicine. New and emerging therapies…

Read More >>



PlatformQ Health Education (PQH Education) is pleased to announce that we will be presenting a Lightning Round session at The 2017 Alliance Industry Summit (AIS 2017) May 22-24, 2017 in Philadelphia, PA. The AIS is an annual meeting of stakeholders in the Continuing Medical Education space that focuses on needs, accomplishments, and insights of industry…

Read More >>


PlatformQ Health Education (PQH Education) is pleased to announce that we will be presenting a session at The 2017 Alliance Quality and Innovation Summit September 25-27, 2017 in Park City, Utah. The session, titled Investigating the Impact of Patient Education on Self-Efficacy and Health Communication, will be presented by Wendy Turell, DrPH, VP of CME…

Read More >>


Much speculation filled the news about Zika virus over the past year. We watched as news filtered out from Brazil and other countries about the increasing incidence of microcephaly in newborn babies from mothers who were infection with the virus. And, as fears mounted, we witnessed its arrival in the US. What is Zika? Zika…

Read More >>


Crohn’s disease is still a challenge to diagnose and treat. Clinicians have come a long way in diagnosing and treating Crohn’s disease since 1984, when Michael Weiss was first diagnosed. Yet this prolific and severe illness has no known cause or cure. In this first segment looking into the experience of patients living with chronic and…

Read More >>


This OMEDLIVE presentation is Part Two of a two-part series surrounding Pediatric Neuroblastomas. During the conversation, Dr. Jason Shohet and Jennifer Saggio, MSN, CRNP, CPON focus on the following areas: Overview of pathology and standard therapy for high-risk NB Required imaging and evaluations for the revised INRGSS system Overall treatment scheme, including recent proposed changes…

Read More >>


A recap of OMedLive’s online CME program, Immunotherapy: Shifting the Lung Cancer Treatment Paradigm, which aired live on November 3rd, 2016. According to the American Cancer Society, lung cancer is the leading cause of cancer deaths in most countries. In 2015, the US saw 221,000 new cases of lung cancer (13% of all cancer cases)…

Read More >>



In this CME offering presented by the Primary Care Network and Diabetes Series Live, Drs. Richard Beaser, Associate Professor of Medicine and Harvard Medical School and Nuha El Sayed, Director of International Programs at Joslin Diabetes Center introduce and educate viewers on a relatively new class of drugs to combat Type II Diabetes; the SGLT-2…

Read More >>


Our medical directors compiled this clinical reference chart for injectables used to treat diabetes. It is current as of September 2016, and lists the class, onset, dose and peak for each medication. Physicians, nurses and other health care providers can refer to the digital chart or print the two-page pdf for wall posting. To find…

Read More >>



Zika Virus is in the news, people are concerned about this epidemic expanding through the U.S. protectorates and threatening the continental U.S. and Hawaii. We’re at the early stages of understanding this virus and there is much misinformation and uncertainty surrounding this new global pathogenic threat. While the anxiety is wide-spread, the Center for Disease…

Read More >>


Zika, already a problem in Puerto Rico, American Samoa, and the U.S. Virgin Islands, should reach the mainland U.S. as seasonal temperatures climb and the mosquito responsible for transmission becomes active. To date, there have been 273 travel-associated cases of Zika in U.S. States, 19 are in pregnant women and six were sexually transmitted. In…

Read More >>


The Association for Comprehensive Care in Rare Diseases (ACCORD) recently conducted a novel survey around primary care in patients with rare diseases. To better understand physicians’ viewpoint on the topic, the team at ACCORD conducted a survey of 536 clinicians who reported having at least one patient in their practice who received care from a…

Read More >>


In this recent CME offering from ClinicalSeriesLive, “The Advancement of Biosimilars: A New Frontier in Medicine, Clinical Applications and Concerns Regarding Biosimilar Products,” viewers gain valuable insight into the testing, approval, and use of biosimilars or treatment of various diseases. As of the production of the video, the only biosimilar approved by the FDA is…

Read More >>



Editor’s note: This article on new treatment options for heart failure also applies to HCPs caring for patients living with diabetes. Our sister site, CardioCareLive.com, hosted this online CME session.  In the United States there are about 5.7 million people diagnosed with heart failure (HF), most of them female. With 870,000 new HF patients diagnosed annually, the 2012…

Read More >>


In this CME offering from NeuroSeriesLive, Dr. Dennis Dlugos takes viewers through the current best practices for pediatric epilepsy. Using two case studies, Dr. Dlugos discusses diagnosis challenges and considerations, goals and concerns of medication treatments, and offers several non-medical treatment options. Dr. Dlugos, Professor of Neurology and Pediatrics at the Perelman School of Medicine…

Read More >>


Editor’s note: This article on CVD Residual Risk addresses the HCP treatment and management of patients living with diabetes who have an increased risk for heart disease.  If you are interested in more information you can visit our sister site, CardioCareLive for more information.  An expert cardiologist, takes an in-depth look at CVD residual risk. Topics covered…

Read More >>


Melanoma accounts for less than two percent of all skin cancers but it is the cause of most skin cancer deaths. Just over 10,000 patients a year die from the disease. These sober statistics sparked a focus on new treatments to decrease mortality rates, such as BRAF and MEK inhibitors.  The FDA has approved two…

Read More >>


Migraine headaches are a debilitating collection of neurological symptoms often accompanied by one or more of the following: visual disturbances, nausea, vomiting, dizziness, extreme sensitivity to sound, light, touch, and smell, and tingling or numbness in the extremities or face. A common disorder, about 30 million people in America suffer fro6m this condition to varying…

Read More >>


Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium which causes infections in different parts of the body. In the United States, MRSA accounts for an average of 59 percent of all emergency room admissions for patients with skin and soft tissue infections (SSTI). Although this percentage varies across the country, clearly attention must be given to…

Read More >>



When we take a look at the 10 most significant invasive fungal infections worldwide, over 2 million cases are reported each year, with a startlingly high average mortality rate of 45%. This war against invasive mycoses demands an urgent need for efficient diagnostic tests and safe and effective new drugs and vaccines. In this CME…

Read More >>


According to the American Cancer Society, there were approximately 221,000 new cases of lung cancer in the U.S. in 2015. These patients accounted for about 13% of all new cancers. Of those, nearly 85-to-90 percent are non-small cell lung cancer (NSCLC). In this offering from OMedLive, Drs. Panos Fidias and Mark Socinski address some of…

Read More >>


  In this CME offering, Dr. Trevor Van Schooneveld uses clinical trial results, his personal knowledge, and his passion for Antimicrobial Stewardship as he explains how we can better treat in-hospital gram-negative infections. Dr. Schooneveld, Associate Professor of Infectious Disease as well as the Medical Director of the Antimicrobial Stewardship Program at the University of…

Read More >>


In March of 2015, the FDA approved the first biosimilar for use with American patients. In the next five years, the market is expected to expand to $60 billion in sales in the U.S. and $127 billion worldwide. On February 1st, from 10 am – noon, EST, OMedLive in partnership with ClinicalSeriesLive, will be presenting…

Read More >>


Drs. Wasif Saif and Bert H. O’Neil take on some of the most recently approved treatment methods for metastatic colo-rectal cancer (mCRC) and compare their efficacy, risks, and benefits against other treatments options — some in use for the past half-century. Colo-rectal cancer is the second leading cause of cancer death in the United States;…

Read More >>


In this OMedLive video, nurses Brenda Riske and Regina B. Butler discuss “optimizing outcomes in hemophilia treatment” from a nurse’s perspective. Hemophilia, a genetic bleeding disease, affects about 20,000 Americans and over 400,000 people worldwide. A rare and serious condition, it requires a vigilant medical team for optimal patient care. Brenda Riske, RN, MSN, MBA,…

Read More >>


In this continuing medical education video session, Dr. Tanios Bekaii-Saab tells us, “in the last 30 years, overall five-year relative survival rates increased for most cancers except for lung and pancreatic cancers, which have shown the least improvement.” In terms of mortality, pancreatic cancer is the fourth leading type of cancer death for both men…

Read More >>


NeuroSeriesLive and Jefferson Headache Center announce their upcoming event, “Treatment Choices in Acute Migraine Management: Selecting Appropriate Use for Individual Patients.” The interactive online CME session includes Stephen D. Silberstein, MD and Michael J. Marmura, MD from the Center. Dr. Silberstein, the Director of the Jefferson Headache Center, Thomas Jefferson University and his colleague Dr.…

Read More >>


Individualized management of a patient’s insulin regimen is a must. It is not without many challenges, however, as Richard Beaser, MD, Associate Clinical Professor of Medicine at Harvard Medical School, George Dailey III, MD, Head of Diabetes Research and Medical Director of the Scripps Whittier Diabetes Institute, and Jason Gaglia, MD, MMSc, Assistant Professor of…

Read More >>



Drs. Caroline M. Apovian and Louis J. Aronne examine the 2013 AHA/ACC/TOS Guideline for Management of Overweight and Obesity in Adults, paying special attention to the recommendation to advise obese adults who meet criteria that surgery may be an option in “Updates in Bariatric Surgery: Guidelines, Patient Selection,” presented by DiabetesSeriesLive.” Dr. Caroline M. Apovian,…

Read More >>


By: by Rachel Nall, RN, BSN, CCRN Incorporating more insulin into a patient’s treatment plan can be difficult. In “Overcoming Barriers to Insulin Intensification: Case Discussions – Part 1,” diabetes experts address issues surrounding initial insulin treatment by examining case studies with the goal of helping clinicians learn how to approach common clinical scenarios. Presenters…

Read More >>


Primary care providers are often the first line of defense in ensuring those with diabetes get timely care for their eyes, according to physicians in the presentation “Diabetic Retinopathy: Role of the Primary Care Provider in the Optimal Care Model – Strategies for Prevention and Risk Reduction,” a CME video for the education summit DiabetesSeriesLive.…

Read More >>


  The 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference, held October 7 through October 10, 2015, in Barcelona, Spain, featured presentations on personalized therapies, updated clinical trials, risk management, and therapeutic strategies for multiple sclerosis treatments. The treatments are likely to be ones doctors will explore for…

Read More >>


Diabetic retinopathy treatment requires a team approach. A care team comprises primary care physicians, endocrinologists, ophthalmologists and other specialists. To gain insights into the emerging approaches from the ophthalmologist’s perspective, DiabetesSeries Live created “Achieving Better Outcomes for Patients With Diabetic Retinopathy: The Expanding Role of the Ophthalmologist.” This interactive presentation features speakers Andrew A. Moshfeghi,…

Read More >>



  Lennox-Gastaut Syndrome is a form of childhood epilepsy that requires careful diagnosis, treatment and transitional management into adulthood. In “Lennox-Gastaut Syndrome Across the Lifespan: Improving Diagnosis and Management,” a presentation from NeuroSeriesLive, experts Gregory L. Krauss, MD, from Johns Hopkins School of Medicine, and John M. Pellock, MD, at Virginia Commonwealth University discuss the…

Read More >>


By: Rachel Nall, RN, BSN, CCRN Editors Note: This CME session has expired. You can no longer earn CME from this session, however, NeuroSeriesLive.com has many other CME programs, including in Alzheimer’s. To get the latest information, go to NeuroSeriesLive.com After more than three decades of using the same diagnostic criteria for Alzheimer’s disease, recent…

Read More >>


Lennox-Gastaut Virtual CME Symposium Live, Complimentary Online Medical Education Wednesday, November 4, 2015 from 11:00 am – 12:00 noon ET Featured Speakers Gregory L. Krauss, MD Johns Hopkins School of Medicine John M. Lellock, MD Virginia Commonwealth University   Topics include Disease characteristics that may suggest a patient has LGS Differences associated with LGS from…

Read More >>


Our recent event, “New Direction in the Assessment and Management of Patients with Alzheimer’s Disease” was a success with several hundred doctors attending the interactive online broadcast. We compiled a Q&A section of questions from clinicians about the latest treatment and diagnostic options. Dementia Treatment and Diagnostic Options Overall, “eight to 10 million Americans suffer…

Read More >>